Have you been diagnosed with Crohn’s Disease?

You may be eligible to participate in
a new clinical study evaluating Cannabidiol (CBD)
as steroid sparing therapy

At a glance:

Condition: Steroid dependent Crohn’s disease
Study treatment: CBD oil
Treatment duration: 1 year
Phase: IIa           Enrollment Goal: 30 patients
Region: Multi Center in Israel

Clinical Trial Approach

If you are eligible to participate, you will be randomized into CBD or placebo group in a ratio of 2:1.

Standard of Care (steroids and additional therapies) will be administered according to your need during the first weeks of the study in addition to increasing doses of CBD. At the conclusion of the dose escalation segment of the study, weekly tapering off of steroids will commence and you will continue receiving the CBD or placebo for an additional period of 8 months.

Patients in placebo that do not show improvement in the first 3 months, will receive CBD for the additional months of the trial.

What is CBD oil?

Cannabidiol (CBD) is a non-psychotropic ingredient of Cannabis sativa which possesses potent immunomodulatory and anti-inflammatory properties.

Our medical grade CBD formulation is administered in an exact dosage form under strict medical care.

The safety of CBD has been demonstrated already by our team in other clinical studies as well as by others in animals and clinical studies of the cardiovascular, respiratory and central nervous systems.

Are you eligible to participate?


SDCD Research (Crohn's) Meir
Dr. Timna Naftali / Irina Dimamt

Important Information to Consider
There’s a lot to think about when considering whether to volunteer for a clinical study. Any clinical study includes risks, which the study doctor will review with you.    Also, this is not a complete overview of study criteria. A study doctor will review your information to see if you qualify.

About Us:
STERO Biotechs Ltd. Founded in 2017 and headquartered in Israel, is a clinical-stage company committed to the research and development of novel Cannabidiol (CBD) based treatments and solutions that will potentially benefit millions of patients by reducing the side effects and the need of steroid therapy.

STERO Biotechs Ltd. committed to the research and development of novel and improved Cannabidiol (CBD) based treatment solution.   STERO aims to solve this unmet need by offering CBD based treatment that will reduce Steroids’ dosage and therefore, their side effects.       Read More >>